Treatment with monoclonal antibodies against Clostridium difficile toxins.
Safdar
Amar
A
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000992:Antitoxins / Q000627:therapeutic use; D001426:Bacterial Proteins / Q000276:immunology*; D001427:Bacterial Toxins / Q000276:immunology*; D016360:Clostridioides difficile; D003015:Clostridium Infections / Q000188:drug therapy*; D003967:Diarrhea / Q000188:drug therapy / Q000382:microbiology; D004359:Drug Therapy, Combination; D004768:Enterotoxins / Q000276:immunology*; D006801:Humans
D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D000992:Antitoxins; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D004768:Enterotoxins; C041348:tcdA protein, Clostridium difficile; C031815:toxB protein, Clostridium difficile